 |
Keitel V, Kreissl MC, Goetze T, Dröge C, Kuhn CK, Pham NN, Löffler D, Borie D, Schreiber J, Boettcher M, Hippe K, Pech M, Mikusko M, Köhl U, Walther D, Reiche K, Mougiakakos D. CAR T-cell therapy induces remission in multiorgan IgG4-related disease with hepatobiliary involvement. J Hepatol. 2026 Apr;84(4):829-836.
|
|
|
|
Wiemers TC, Grieb N, Ferle M, Rade M, Fandrei D, Born P, Fischer L, Wang SY, Seiffert S, Grahnert A, Friedrich M, Baber R, Kreuz M, Metzeler KH, Herling M, Herling CD, Jentzsch M, Franke GN, Boldt A, Neumuth T, Köhl U, Reiche K, Stegmann T, Denecke T, Platzbecker U, Vučinić V, Meyer HJ, Lavall D, Merz M. MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving
cilta-cel. Leukemia. 2026 Apr;40(4):832-836.
|
|
|
|
Ferle M, Ader J, Wiemers T, Grieb N, Berneck B, Lindenmeyer A, Goldschmidt H, Mai EK, Bertsch U, Meyer HJ, Neumuth T, Kreuz M, Reiche K, Merz M. Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligence. NPJ Digit Med. 2026 May 11;9(1):363.
|
|
|
|
Freudenberg-Jahn K, Ben-Horin I, Murali Shankar N, Schuldt M, Ortiz-Montero P, Loureiro LR, Rackwitz W, Opitz C, Krutz L, Breither T, Oberoi P, Häcker A, Jäger D, Kuhlmann JD, Wimberger P, Künzel SR, Hölig K, Feldmann A, Bachmann M, Wels WS, Tonn T, Eitler J. Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneity. J Exp Clin Cancer Res. 2026 May 19;45(1):127.
|
|
|
|
Save the Date – SaxoCell Trainings and Events
